Search results

1 – 2 of 2
Per page
102050
Citations:
Loading...
Access Restricted. View access options
Article
Publication date: 19 May 2023

Fernanda Steiner Perin and Julia Paranhos

This study aims to analyse how different types of public policies have supported the internationalisation of latecomer science-based firms, taking the case of large Brazilian…

157

Abstract

Purpose

This study aims to analyse how different types of public policies have supported the internationalisation of latecomer science-based firms, taking the case of large Brazilian pharmaceutical companies (LBPCs).

Design/methodology/approach

The methodology comprises a multiple case study and uses a literature review, fieldwork interviews and document analysis of eight LBPCs, five policymakers and three sector experts.

Findings

Direct and indirect policies differ in supporting LBPCs’ internationalisation motivation. The indirect policies created the necessary conditions to accumulate knowledge and capacity in the domestic market. LBPCs that adhere more to policies supporting production and technological capabilities development are internationalising as an extension of their innovative efforts. In contrast, LBPCs that have built productive capacities and have not yet reached a minimum level of technological capacity go abroad to exploit their production capabilities with the support of direct policies.

Originality/value

This study contributes to international business and evolutionary literature, demonstrating the channels through which public policies support latecomer science-based firms. The results show that direct and indirect policies assist firms’ internationalisation in different ways, according to actors’ perception: providing support to strengthen their domestic capabilities, which have become competitive advantages in the international market; or offering support to external expansion. It emphasises that industrial policies are relevant to support companies in creating the initial conditions (ownership advantages) to internationalise, and direct policies are important to help companies to design international strategies. This study also debates that policies supporting companies’ internationalisation depend on their adhesion to programmes and incentives and their routines and capabilities, which are specific to each company and lead to different motivations for international expansion.

Details

Multinational Business Review, vol. 31 no. 4
Type: Research Article
ISSN: 1525-383X

Keywords

Access Restricted. View access options
Article
Publication date: 19 September 2019

Julia Paranhos, Fernanda Steiner Perin, Eduardo Mercadante and Caroline Soares

The purpose of this paper is to analyze the strategies and organizational forms used by large Brazilian pharmaceutical companies (LBPCs) in interaction with universities for the…

274

Abstract

Purpose

The purpose of this paper is to analyze the strategies and organizational forms used by large Brazilian pharmaceutical companies (LBPCs) in interaction with universities for the development of innovation.

Design/methodology/approach

In the pharmaceutical industry, a science-based sector, the source of new knowledge is often outside the company environment. Thus, the search for innovation depends on the company’s strategic decisions of cooperation. This research uses the case study method, with secondary data from the 2008, 2011 and 2014 Innovation Survey (Pintec) about the innovative efforts of LBPCs, as well as primary data from semi-structured interviews with six of them.

Findings

The most recent data on innovation in Brazil show changes in the innovative efforts of LBPCs, involving the raise in the interaction with universities. The results of the field research also show that the LBPCs have differentiated innovative structures and are effectively using strategies for partnerships with universities, through the creation of radical innovation departments, the establishment of internal scientific committees and the internationalization of research and development.

Originality/value

These findings contribute to the literature on the industry-university interactions in Brazil and in developing countries. However, this analysis cannot be generalized for the Brazilian pharmaceutical industry as it uses the case study method. Moreover, it is too early to determine if the identified strategies were successful. Nonetheless, it is worth mentioning that the strategies of the six interviewed companies differ greatly from the patterns of the Brazilian pharmaceutical industry and the manufacturing industry.

Objetivo

El objetivo de este artículo es analizar las estrategias y estructuras organizacionales de las grandes empresas farmacéuticas brasileñas (GEFBs) en la interacción con universidades para el desarrollo innovador. En la industria farmacéutica, un sector basado en la ciencia, la fuente del conocimiento suele estar fuera del ambiente de la empresa. Por lo tanto, la búsqueda de la innovación depende de las decisiones estratégicas de cooperación de la empresa.

Diseño/metodología/aproximación

Esta investigación utiliza el método de estudio de caso, a partir de datos secundarios de la Encuesta de Innovación (Pintec) de 2008, 2011 y 2014 sobre los esfuerzos innovadores de las GEFBs, así como datos primarios de entrevistas semiestructuradas con seis de ellas.

Resultados

Los datos más recientes sobre innovación en Brasil muestran cambios en los esfuerzos innovadores de las GEFBs, incluyendo ampliación de la interacción con universidades. Los resultados de la investigación de campo también indican que las GEFBS poseen estructuras innovadoras diferenciadas y están aplicando estratégicas de alianzas con universidades, por la creación de departamentos de innovación radical, por el establecimiento de comités científicos internos y por la internacionalización de la investigación e innovación.

Limitaciones de la investigación/implicaciones

Este análisis no puede ser generalizado para la industria farmacéutica brasileña por utilizar el método de estudio de caso. Además, es muy temprano para determinar si las estrategias identificadas obtuvieron éxito.

Palabras claves

Estrategias empresariales, interacción universidad-empresa, Brasil

Tipo de artículo

Estudio de caso

Originalidad/valor

Estos resultados contribuyen a la literatura sobre interacciones universidad-empresa en Brasil y en países en desarrollo. Asimismo, debe ser mencionado que las estrategias de las seis empresas entrevistadas difieren considerablemente de los padrones de la industria farmacéutica y de la industria de transformación brasileñas.

Objetivo

O objetivo deste artigo é analisar as estratégias e estruturas organizacionais das grandes empresas farmacêuticas brasileiras (GEFBs) na interação com universidades para o desenvolvimento inovativo. Na indústria farmacêutica, um setor baseado em ciência, a fonte do conhecimento costuma estar fora do ambiente da empresa. Portanto, a busca pela inovação depende das decisões estratégicas de cooperação da empresa.

Design/metodologia/abordagem

Esta pesquisa utiliza o método de estudo de caso, a partir de dados secundários da Pesquisa de Inovação (Pintec) de 2008, 2011 e 2014 sobre os esforços inovativos das GEFBs, assim como dados primários de entrevistas semiestruturadas com seis delas. Os dados mais recentes sobre inovação no Brasil mostram mudanças nos esforços inovativos das GEFBs, incluindo a ampliação da interação com universidades.

Resultados

Os resultados da pesquisa de campo também indicam que as GEFBs possuem estruturas inovativas diferenciadas e estão efetivamente aplicando estratégicas de parcerias com universidades, pela criação de departamentos de inovação radical, pelo estabelecimento de comitês científicos internos e pela internacionalização da pesquisa e inovação.

Limitações de pesquisa/implicações

Esta análise não pode ser generalizada para a indústria farmacêutica brasileira por utilizar o método de estudo de caso. Ademais, é muito cedo para determinar se as estratégias identificadas obtiveram sucesso.

Originalidade/valor

Esses resultados contribuem para a literatura sobre interações universidade-empresa no Brasil e em países em desenvolvimento. Outrossim, deve ser mencionado que as estratégias das seis empresas entrevistadas diferem consideravelmente do padrão da indústria farmacêutica e da indústria de transformação brasileiras.

Palavras chaves

Estratégias empresariais, interação universidade-empresa, indústria farmacêutica, Brasil

Tipo de artigo

Estudo de caso

Details

Management Research: Journal of the Iberoamerican Academy of Management, vol. 17 no. 4
Type: Research Article
ISSN: 1536-5433

Keywords

1 – 2 of 2
Per page
102050